Drug updated on 11/10/2023
|Injection (intravenous; 1 mg)
| Ongoing and
- For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Product Monograph / Prescribing Information
|Yondelis (trabectedin) Prescribing Information.
|Janssen Products, LP, Horsham, PA
Systematic Reviews / Meta-Analyses
|Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).
|Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature
|Frontiers in oncology